tiprankstipranks
Novabay Pharmaceuticals (NBY)
:NBY
US Market

NovaBay Pharma (NBY) Financial Statements

Compare
648 Followers

NovaBay Pharma Financial Overview

NovaBay Pharma's market cap is currently $3.49M. The company's EPS TTM is $-35.469; its P/E ratio is ―; NovaBay Pharma is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 14.73M$ 14.40M$ 8.42M$ 9.93M$ 6.60M
Gross Profit$ 7.89M$ 7.78M$ 5.64M$ 5.96M$ 4.86M
Operating Income$ -5.00M$ -7.68M$ -8.86M$ -6.43M$ -9.40M
EBITDA$ -4.80M$ -7.20M$ -8.74M$ -6.38M$ -9.34M
Net Income$ -9.64M$ -16.27M$ -6.56M$ -11.04M$ -10.49M
Balance Sheet
Cash & Short-Term Investments$ 3.13M$ 5.36M$ 7.50M$ 11.95M$ 6.94M
Total Assets$ 9.03M$ 16.40M$ 23.98M$ 15.24M$ 11.22M
Total Debt$ 2.74M$ 2.04M$ 551.00K$ 503.00K$ 4.05M
Net Debt$ -390.00K$ -3.32M$ -6.95M$ -11.45M$ -2.89M
Total Liabilities$ 5.72M$ 5.84M$ 13.81M$ 2.92M$ 10.25M
Stockholders' Equity$ 3.31M$ 10.55M$ 10.17M$ 12.32M$ 973.00K
Cash Flow
Free Cash Flow$ -4.15M$ -6.77M$ -9.24M$ -4.75M$ -7.95M
Operating Cash Flow$ -4.13M$ -6.65M$ -9.19M$ -4.72M$ -7.93M
Investing Cash Flow$ -19.00K$ -112.00K$ -12.04M$ -26.00K$ -19.00K
Financing Cash Flow$ 1.91M$ 4.63M$ 16.79M$ 9.76M$ 11.70M
Currency in USD

NovaBay Pharma Earnings and Revenue History

NovaBay Pharma Debt to Assets

NovaBay Pharma Cash Flow

NovaBay Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis